Desmond Curran, Brandon J. Patterson, Desiree Van Oorschot, Philip O. Buck, Justin Carrico, Katherine A. Hicks, . . . Barbara P. Yawn. (2019). Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live. Taylor & Francis Group.
Chicago Style (17th ed.) CitationDesmond Curran, Brandon J. Patterson, Desiree Van Oorschot, Philip O. Buck, Justin Carrico, Katherine A. Hicks, Bruce Lee, and Barbara P. Yawn. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in Older Adults in the United States Who Have Been Previously Vaccinated with Zoster Vaccine Live. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationDesmond Curran, et al. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in Older Adults in the United States Who Have Been Previously Vaccinated with Zoster Vaccine Live. Taylor & Francis Group, 2019.